112 related articles for article (PubMed ID: 1711585)
1. Preparation of AHTG-DNR conjugates and their antitumor effect in vitro.
Zhang DH; Tang JZ; Shen GX; Shu N; Zhu HF
J Tongji Med Univ; 1990; 10(4):235-9. PubMed ID: 1711585
[TBL] [Abstract][Full Text] [Related]
2. Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.
Styczynski J; Wysocki M; Balwierz W; Kowalczyk JR
Leukemia; 2002 May; 16(5):820-5. PubMed ID: 11986942
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a conjugate of purified antibodies against human AFP-dextran-daunorubicin to human AFP-producing yolk sac tumor cell lines.
Ohkawa K; Hibi N; Tsukada Y
Cancer Immunol Immunother; 1986; 22(2):81-6. PubMed ID: 2424598
[TBL] [Abstract][Full Text] [Related]
4. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin.
Yokota S; Hara H; Luo Y; Seon BK
Cancer Res; 1990 Jan; 50(1):32-7. PubMed ID: 2293557
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.
Biddle WC; Haruta Y; Seon BK; Henderson ES; Sarcione EJ
Leuk Res; 1989; 13(8):699-707. PubMed ID: 2529399
[TBL] [Abstract][Full Text] [Related]
6. [Study on the reversing effect of tripiperaquine on human multidrug resistant leukemic cell line K562/A02].
Yang R; Yang C; Hao Y
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):340-2. PubMed ID: 8697970
[TBL] [Abstract][Full Text] [Related]
7. Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells.
Sweet F; Rosik LO; Sommers GM; Collins JL
Gynecol Oncol; 1989 Sep; 34(3):305-11. PubMed ID: 2788601
[TBL] [Abstract][Full Text] [Related]
8. Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells.
Liu FT; Kelsey SM; Newland AC; Jia L
Br J Haematol; 2002 May; 117(2):333-42. PubMed ID: 11972515
[TBL] [Abstract][Full Text] [Related]
9. Daunorubicin coupled to monoclonal antibodies via a cis-aconitic anhydride linker: biochemical and cytotoxic properties revisited.
Ahmad A; Law KL; Young B; Telander MW; Ogden JR; Leung K
Anticancer Res; 1990; 10(3):837-43. PubMed ID: 2369097
[TBL] [Abstract][Full Text] [Related]
10. Human ovarian cancers specifically bind daunorubicin-OC-125 conjugate: an immunofluorescence study.
Dezsö B; Török I; Rosik LO; Sweet F
Gynecol Oncol; 1990 Oct; 39(1):60-4. PubMed ID: 2227573
[TBL] [Abstract][Full Text] [Related]
11. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
[TBL] [Abstract][Full Text] [Related]
12. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.
Lotfi K; Zackrisson AL; Peterson C
Cancer Lett; 2002 Apr; 178(2):141-9. PubMed ID: 11867198
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of a monoclonal antibody (HI30)-mitomycin C conjugate utilizing dextran T-40 and its specific cytotoxicity against human leukemia cell line CEM].
Zhu Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Aug; 12(4):274-80. PubMed ID: 1701360
[TBL] [Abstract][Full Text] [Related]
14. Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy.
Lai BB; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):345-51. PubMed ID: 19379564
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia.
Schröder JK; Kasimir-Bauer S; Seeber S; Scheulen ME
J Cancer Res Clin Oncol; 2000 Feb; 126(2):111-6. PubMed ID: 10664252
[TBL] [Abstract][Full Text] [Related]
16. [Cytotoxic effect of anticancer drug combined with anti-AFP antibody on human hepatoma cell in vitro].
Kukita K
Hokkaido Igaku Zasshi; 1990 May; 65(3):254-65. PubMed ID: 1696238
[TBL] [Abstract][Full Text] [Related]
17. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
Zhou RQ; Gong YP; Zheng BH; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
[TBL] [Abstract][Full Text] [Related]
18. Localization and biodistribution of conjugate ATG-Dex-DNR in nude mice as models for human leukemia.
Zhang DH; Tang JZ; Li ZX; Cui WF; Wu H; Zhu HF; Shen GX
J Tongji Med Univ; 1995; 15(2):82-6. PubMed ID: 8731958
[TBL] [Abstract][Full Text] [Related]
19. Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.
de Valeriola DL; Ross DD; Forrest A; Cuddy DP; Egorin MJ
Cancer Chemother Pharmacol; 1991; 29(2):133-40. PubMed ID: 1760856
[TBL] [Abstract][Full Text] [Related]
20. Specific binding and internalization of monoclonal antibody HI98-daunorubicin conjugate by human leukemic cells (HL60).
Liu J; Zhu Z; Liu J; Yin S; Chu Y; Qi S; Yang C; Chen Z
Chin Med Sci J; 1991 Sep; 6(3):157-9. PubMed ID: 1793879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
